Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients
Condition(s):Type 2 DiabetesLast Updated:January 19, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Type 2 DiabetesLast Updated:January 19, 2024Recruiting
Condition(s):Diabetes Mellitus, Type 2; Severe Insulin Deficient DiabetesLast Updated:May 23, 2022Recruiting
Condition(s):Ejection FractionLast Updated:March 8, 2023Recruiting
Condition(s):Type 2 DiabetesLast Updated:November 1, 2023Recruiting
Condition(s):Diabetes Mellitus; Cellular Senescence; Sodium-Glucose Transporter 2 InhibitorsLast Updated:August 4, 2023Not yet recruiting
Condition(s):Type 2 Diabetes Mellitus; Cardiovascular DiseasesLast Updated:November 24, 2023Recruiting
Condition(s):Diabetic Peripheral NeuropathyLast Updated:June 7, 2022Recruiting
Condition(s):Diabetes Mellitus, Type 2Last Updated:June 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.